4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-097491
Interim CEO & General Counsel gave up 24,339 shares (to pay taxes)
- Interim CEO & General Counsel acquired 57,292 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Vogt Frederick G · Interim CEO & General Counsel
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-03 | Exercise or conversion : show line 1 in the form | +10,417 | 169,726 | D | ||
| 2024-09-03 | Shares withheld for taxes : show line 2 in the form | −4,426 | $10.85 | $48,022 | 165,300 | D |
| 2024-09-03 | Exercise or conversion : show line 3 in the form | +46,875 | 212,175 | D | ||
| 2024-09-03 | Shares withheld for taxes : show line 4 in the form | −19,913 | $10.85 | $216,056 | 192,262 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-03 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −10,417 | 62,504 | D |
| 2024-09-03 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −46,875 | 46,875 | D |
Loading xslF345X05/tm2423453-4_4seq1.xml…